Question 1

What is the Meaning of Val158Met?

Accepted Answer

Val158Met denotes a common genetic variation, specifically a single nucleotide polymorphism (SNP), within the Catechol-O-methyltransferase (COMT) gene, where the amino acid Valine (Val) at position 158 is replaced by Methionine (Met). This specific alteration influences the enzyme's catalytic efficiency.

Question 2

What is the Context of Val158Met?

Accepted Answer

The COMT enzyme, central to this polymorphism, functions primarily in the catabolism of catecholamines, including dopamine, norepinephrine, and epinephrine, as well as catechol estrogens. Its activity is particularly relevant in the prefrontal cortex, affecting cognitive function, and in peripheral tissues, influencing hormonal balance and detoxification pathways.

Question 3

What is the Significance of Val158Met?

Accepted Answer

This polymorphism holds clinical significance due to its impact on neurotransmitter degradation rates, influencing an individual's stress response, pain perception, and susceptibility to certain neuropsychiatric conditions like anxiety, depression, and obsessive-compulsive disorder. It also affects the metabolism of estrogen, potentially altering breast cancer risk and response to hormone therapies.

Question 4

What is the Mechanism of Val158Met?

Accepted Answer

The Val158Met substitution affects the thermal stability of the COMT enzyme, with the methionine variant (Met) leading to reduced enzyme activity compared to the valine variant (Val). This decreased activity of the Met allele results in slower degradation of catecholamines and catechol estrogens, potentially leading to higher sustained levels of these compounds in synaptic clefts and tissues.

Question 5

What is the Application of Val158Met?

Accepted Answer

Understanding an individual's Val158Met genotype can inform personalized approaches in clinical practice, particularly concerning pharmacogenomics for antidepressant and antipsychotic medications, where COMT activity can predict treatment response. It also guides lifestyle and nutritional interventions aimed at supporting optimal neurotransmitter balance and hormone metabolism, especially for individuals with the lower-activity Met allele.

Question 6

What is the Metric of Val158Met?

Accepted Answer

The Val158Met polymorphism is typically assessed through genetic testing, usually performed on a saliva or blood sample, to determine an individual's genotype (Val/Val, Val/Met, or Met/Met). While direct measurement of COMT enzyme activity is possible, genetic analysis is the standard clinical metric for this specific polymorphism.

Question 7

What is the Risk of Val158Met?

Accepted Answer

Misinterpretation or overemphasis of Val158Met genetic results without considering the broader clinical context and other genetic or environmental factors can lead to inappropriate interventions or unnecessary anxiety. There are no direct "risks" associated with the polymorphism itself, but rather with how its implications are managed or mismanaged in a clinical or personal health context, particularly regarding medication choices or unverified supplement use.

Val158Met

Meaning

Context

Significance

Mechanism

Application

Metric

Risk

What Are the Clinical Implications of COMT Gene Polymorphisms for Male Estrogen Levels?

What Are the Specific Genetic Markers Relevant to Estrogen Metabolism?

How Can Genetic Testing Inform Personalized Hormone Therapy Protocols?